ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Charles Smart To Give Up Commission On Cancer Post, Kansas Surgeon To Become Fulltime Director

April 15, 1983

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

Longer Awards, Annual Recompetition considered For “CCOP 3;” Concept to DCPC Board In January

July 15, 1988

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

Drug Reimbursement: Senate Bill Worse For Oncologists

July 11, 1997